Available in 50ml sample bottles or in bulk



GW0742 was developed by Glaxo Smith Kline who were also responsible for developing Cardarine. Research into Cardarine was abandoned by Glaxo Smith Kline in favour of GW0742, presumably due to GW0742 having a much better side effect profile and being more effective at its targeted use.

GW0742 is a synthetic compound that belongs to a class of chemicals known as peroxisome proliferator-activated receptor delta (PPARδ) agonists. It is undergoing clinical investigation as a chemical of interest for various health conditions. GW0742 has been used by athletes for quite a significant length of time now. GW0742 seems to express many benefits to those wishing to improve body composition and boost aerobic performance.

As GW0742 has been shown to boost endurance and fat metabolism as an energy source it has been anecdotally shown to improve strength gain over time. This strength gain comes about because of its ability to improve workout duration and intensity.

GW0742 helps muscle cells use stored fats as energy and encourages adipose cells and liver cells to release their fats to be used as an energy source. This has been shown to have a whole host of metabolic benefits: –

1. Fat Metabolism: GW0742 has been studied for its ability to enhance fat metabolism and increase the utilisation of stored fat for energy. This may contribute to fat loss and improved body composition.

2. Increased Endurance: Some research suggests that GW0742 can enhance endurance and exercise performance by increasing the capacity for fatty acid oxidation. This could potentially lead to more effective workouts and greater calorie expenditure.

3. Potential for Weight Loss: The increased fat utilisation and improved metabolic efficiency associated with GW0742 could lead to weight loss when combined with a healthy diet and exercise regimen.

4. Insulin Sensitivity: PPARδ agonists like GW0742 may also have a positive impact on insulin sensitivity, which is important for regulating blood sugar levels and reducing the risk of insulin resistance.

5. Cardiovascular Health: There is some evidence to suggest that PPARδ agonists may have a positive effect on cardiovascular health by improving lipid profiles and reducing inflammation.

6. Improved body composition: The increased use of fat as an energy source combined with being able to train harder and for longer means GW0742 has a positive effect on lean body mass.

Click below to order 50ml sample bottles of our GW0742 or contact us to order in bulk.

We sell research chemicals on this site to be purchased for research purposes only, not as sports supplements or for human consumption.
By purchasing from this site you agree to use any products supplied solely for use in vitro research only.




Click on the contact below to chat on WhatsApp

× Contact Us